PRO: maintenance is cost-effective Source: Annual Congress 2012 - Pro/Con Debate "Cost-effectiveness of maintenance chemotherapy for NSCLC" Year: 2012
Fluticasone/salmeterol combination (FSC) is safe and provides effective long-term (52 week) control in the management of patients with persistent asthma (PA) Source: Eur Respir J 2001; 18: Suppl. 33, 176s Year: 2001
Asthma control: which tools are feasible in primary care? Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice" Year: 2013
CON Source: Annual Congress 2004 - Controversies in the management of acute pulmonary thromboembolism Year: 2004
Four-month regimens: are they feasible? Source: International Congress 2015 – Tuberculosis: short-course chemotherapy Year: 2015
Budesonide/formoterol with an adjustable maintenance plan costs less, and is as effective as fixed dosing Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002
Aiming for total control of asthma with salmeterol/fluticasone propionate (SFC), a cost effective option Source: Eur Respir J 2005; 26: Suppl. 49, 430s Year: 2005
Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study) Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Budesonide/formoterol maintenance and reliever therapy for asthma in general practice: is it cost-effective? Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
Are mobile device applications effective at supporting COPD self-management compared to usual care? Source: International Congress 2019 – M-health/e-health II Year: 2019
Overall asthma control with budesonide/formoterol maintenance and relief vs conventional best practice Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008
Quality control: a necessary, but sometimes overlooked, tool for improving respiratory medicine Source: Eur Respir J 2009; 33: 722-723 Year: 2009
Adjustable maintenance dosing (AMD) with budesonide/formoterol (B/F) meets guideline-defined management goals more effectively than fixed dosing (FD) with B/F or salmeterol/fluticasone (S/FL) Source: Eur Respir J 2004; 24: Suppl. 48, 311s Year: 2004
Physical therapy continuous monitoring in ICU in a large public hospital: an effective strategy to optimize the weaning process in critical patients Source: Annual Congress 2007 - Critical care and airways clearance Year: 2007
Are disease management programs for COPD cost-effective? Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012